Dimensional Fund Advisors LP Has $1.33 Billion Position in UnitedHealth Group Incorporated (NYSE:UNH)

Dimensional Fund Advisors LP boosted its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 0.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,530,199 shares of the healthcare conglomerate's stock after acquiring an additional 16,864 shares during the period. UnitedHealth Group accounts for 0.4% of Dimensional Fund Advisors LP's portfolio, making the stock its 24th largest position. Dimensional Fund Advisors LP owned 0.27% of UnitedHealth Group worth $1,332,051,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in UNH. Texas Capital Bancshares Inc TX lifted its position in UnitedHealth Group by 1.1% during the 3rd quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate's stock valued at $855,000 after acquiring an additional 19 shares during the period. Tealwood Asset Management Inc. grew its stake in shares of UnitedHealth Group by 0.4% in the 4th quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate's stock worth $2,626,000 after buying an additional 19 shares during the last quarter. Atlas Private Wealth Advisors raised its stake in UnitedHealth Group by 1.1% during the fourth quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate's stock valued at $923,000 after buying an additional 19 shares during the last quarter. Prentice Wealth Management LLC grew its stake in shares of UnitedHealth Group by 0.8% in the fourth quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate's stock worth $1,235,000 after acquiring an additional 19 shares during the last quarter. Finally, Baker Avenue Asset Management LP boosted its stake in UnitedHealth Group by 1.7% in the 3rd quarter. Baker Avenue Asset Management LP now owns 1,219 shares of the healthcare conglomerate's stock worth $615,000 after purchasing an additional 20 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on UNH. Deutsche Bank Aktiengesellschaft lifted their target price on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a "buy" rating in a report on Friday, April 19th. StockNews.com lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Thursday, April 18th. Cantor Fitzgerald reiterated an "overweight" rating and issued a $591.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 10th. Piper Sandler increased their price target on UnitedHealth Group from $566.00 to $571.00 and gave the company an "overweight" rating in a report on Wednesday, April 17th. Finally, TD Cowen reduced their price objective on UnitedHealth Group from $607.00 to $546.00 and set a "buy" rating for the company in a research report on Wednesday, April 10th. Four investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of "Moderate Buy" and an average target price of $570.05.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the business's stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Thomas E. Roos sold 858 shares of the business's stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company's stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

UnitedHealth Group Price Performance

UNH traded up $5.78 during trading on Friday, reaching $512.81. 2,784,585 shares of the company traded hands, compared to its average volume of 4,608,288. The company has a market cap of $471.83 billion, a P/E ratio of 31.35, a PEG ratio of 1.47 and a beta of 0.55. The firm has a fifty day simple moving average of $482.28 and a 200 day simple moving average of $511.82. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts' consensus estimates of $6.63 by $0.28. The company had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm's revenue for the quarter was up 8.6% on a year-over-year basis. During the same period in the previous year, the business earned $6.26 earnings per share. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.47%. UnitedHealth Group's dividend payout ratio (DPR) is presently 45.97%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.